Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

Keywords

PravastatinMedicineInternal medicineClinical endpointPopulationProspective cohort studyCholesterolStroke (engine)GastroenterologyRandomized controlled trial

Affiliated Institutions

Related Publications

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

James Shepherd , Gerard J. Blauw , Michael Murphy +17 more

Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Ou...

2002 The Lancet 3358 citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever , Björn Dahlöf , Neil R Poulter +11 more

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol loweri...

2003 The Lancet 3773 citations

Age and gender bias in statin trials

Syamasis Bandyopadhyay

Cardiovascular disease is strongly age-related, and is the leading cause of death in older people. Several well-publicized trials have recently reported that statin drugs (HMG C...

2001 QJM 57 citations

Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)

Curt D. Furberg , Jackson T. Wright , Barry R. Davis +7 more

Pravastatin did not reduce either all-cause mortality or CHD significantly when compared with usual care in older participants with well-controlled hypertension and moderately e...

2002 JAMA 1323 citations

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study

Alex McConnachie , Ameae M. Walker , Michele Robertson +5 more

Five years' primary prevention treatment of middle-aged men with a statin significantly reduces healthcare resource utilization, is cost saving, and increases QALYs. Treatment o...

2013 European Heart Journal 104 citations

Publication Info

Year: 2006
Type: article
Volume: 368
Issue: 9542
Pages: 1155-1163
Citations: 946
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

946

OpenAlex

Cite This

APA Style

                            
                                
                                    Akira Yamamoto, 
                                
                                    Kyoichi Mizuno, 
                                
                                    Yasuo Ohashi
                                
                                et al.
                            
                            (2006). 
                            Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. 
                            The Lancet
                            , 368
                            (9542)
                            , 1155-1163.
                            https://doi.org/10.1016/s0140-6736(06)69472-5
                        

Identifiers

DOI: 10.1016/s0140-6736(06)69472-5